Excitatory amino acids and the blood-brain barrier (BBB)
LeFauconnier, J.M.; Klatzo, I.
Advances in Experimental Medicine and Biology 203: 231-233
1986
ISSN/ISBN: 0065-2598 PMID: 2878562 Document Number: 272186
Document emailed within 1 workday
Related Documents
Pollay, M. 1975: Evaluation of altered blood-brain barrier permeability to amino acids Research Communications in Chemical Pathology and Pharmacology 10(4): 763-766Banks, W.A.; Kastin, A.J. 1986: Modulation of the carrier-mediated transport of the Tyr-MIF-1 across the blood-brain barrier by essential amino acids Journal of Pharmacology and Experimental Therapeutics 239(3): 668-672
Terasaki, T.; Takakuwa, S.; Moritani, S.; Tsuji, A. 1991: Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells Journal of Pharmacology and Experimental Therapeutics 258(3): 932-937
Berg, G.; Matzkies, F. 1978: Behavior of blood amino acids and fatty acids during complete parenteral hyperalimentation with carbohydrates, amino acids and fats Fortschritte der Medizin 96(12): 631-638
Moreno-Fuenmayor, H.; Borjas, L.; Arrieta, A.; Valera, V.; Socorro-Candanoza, L. 1996: Plasma excitatory amino acids in autism Investigacion Clinica 37(2): 113-128
Lasoń, W. 1998: Excitatory amino acids and perspectives of epilepsy treatment Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 5(27): 142-144
Lasoń, W. 1997: The interaction between neuropeptides and excitatory amino acids in seizure phenomena Polish Journal of Pharmacology 49(1): 64-66
Valli, M. 1987: Influence of excitatory amino acids on the outcome of cerebral ischemia Presse Medicale 16(23): 1118-1121
Chapman, A.; Meldrum, B. 1991: Excitatory amino acids in epilepsy and novel anti-epileptic drugs Epilepsy Research. Suppl 3: 39-48
West, M.; Huang, W. 1994: Spinal cord excitatory amino acids and cardiovascular autonomic responses American Journal of Physiology 267(3 Pt 2): H865-H873
Greig, N.H.; Momma, S.; Sweeney, D.J.; Smith, Q.R.; Rapoport, S.I. 1987: Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system Cancer Research 47(6): 1571-1576
Youngren, K.D.; Daly, D.A.; Moghaddam, B. 1993: Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens Journal of Pharmacology and Experimental Therapeutics 264(1): 289-293
Pawlikowski, M.; Kunert-Radek, J. 1995: Failure of excitatory amino acids receptor agonists NMDA and quiscalate to affect the cell proliferation Polish Journal of Pharmacology 47(2): 185-187
Tsukamoto, Y. 1998: Apoptosis induced by excitatory sulfur amino acids in primary cultured rat immature cerebral neurons Rinsho Shinkeigaku 38(12): 1024-1030
Nicolodi, M.; Del Bianco, P.L.; Sicuteri, F. 1997: Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse International Journal of Clinical Pharmacology Research 17(2-3): 97-100
Vigot, R.; Kado, R.T.; Batini, C. 2004: Increased calbindin-D28K immunoreactivity in rat cerebellar Purkinje cell with excitatory amino acids agonists is not dependent on protein synthesis Archives Italiennes de Biologie 142(1): 69-75
Hallak, M.; Irtenkauf, S.M.; Cotton, D.B. 1996: Effect of magnesium sulfate on excitatory amino acid receptors in the rat brain. II. Kainate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors American Journal of Obstetrics and Gynecology 175(3 Pt 1): 582-587
Bustos, G.; Abarca, J.; Fiedler, J.; Araneda, R. 1988: Neurochemistry of the mesencephalic substantia nigra: interrelations between excitatory amino acids, N-methyl-D-aspartate type receptors and intrinsic neuronal systems Archivos de Biologia y Medicina Experimentales 21(1): 59-64
Maeda, T.; Kanda, T. 2013: Blood-brain barrier and blood-nerve barrier in neuroinflammatory diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 71(5): 789-794
Ponnampalam, S.N.; Mayberg, M.R. 2004: Mediators of blood-brain barrier disruption and potential therapeutic interventions for protection of the barrier following focal ischemia Clinical Neurosurgery 51: 112-119